Vu, P.L.; Vadakekolathu, J.; Idri, S.; Nicholls, H.; Cavaignac, M.; Reeder, S.; Khan, M.A.; Christensen, D.; Pockley, A.G.; McArdle, S.E.
A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice. Cancers 2022, 14, 1970.
https://doi.org/10.3390/cancers14081970
AMA Style
Vu PL, Vadakekolathu J, Idri S, Nicholls H, Cavaignac M, Reeder S, Khan MA, Christensen D, Pockley AG, McArdle SE.
A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice. Cancers. 2022; 14(8):1970.
https://doi.org/10.3390/cancers14081970
Chicago/Turabian Style
Vu, Pauline Le, Jayakumar Vadakekolathu, Sarra Idri, Holly Nicholls, Manon Cavaignac, Stephen Reeder, Masood A. Khan, Dennis Christensen, Alan Graham Pockley, and Stéphanie E. McArdle.
2022. "A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice" Cancers 14, no. 8: 1970.
https://doi.org/10.3390/cancers14081970
APA Style
Vu, P. L., Vadakekolathu, J., Idri, S., Nicholls, H., Cavaignac, M., Reeder, S., Khan, M. A., Christensen, D., Pockley, A. G., & McArdle, S. E.
(2022). A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice. Cancers, 14(8), 1970.
https://doi.org/10.3390/cancers14081970
